Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

Share Price is delayed by 15 minutes
Get Live Data
2,576.00    22.00 (0.86%)
Bid:
2,568.00
Ask:
2,570.00
Spread: 2.00 (0.078%)
Market Cap: £8.27b
BNZL Live PriceLast checked at - London Stock Exchange

Intraday Bunzl Share Chart

Trading Statement

16 Dec 2015 07:00

RNS Number : 1475J
Bunzl PLC
16 December 2015
 



 

16 December 2015

 

BUNZL PRE CLOSE STATEMENT AND ACQUISITIONS IN FRANCE, CHILE AND SPAIN

 

Bunzl plc, the international distribution and outsourcing Group, is updating the market today relating to the year ending 31 December 2015 prior to entering its close period.

 

Overall trading is consistent with expectations at the time of the third quarter trading statement in October. At constant exchange rates, Group revenue growth for the year is expected to be approximately 5%, principally due to the positive impact of acquisitions together with some organic growth which continues to be affected by price declines on plastic resin based products, particularly in North America. The Group operating margin should be at the same level as the prior year.

 

Acquisitions continue to be a key part of the Company's strategy for growth and Bunzl also today announces that it has purchased three further businesses in France, Chile and Spain.

 

Comatec SAS, which is based in Carcassonne, France, is engaged in the distribution of high-end, innovative single use tableware to restaurants and hotels throughout France but also exports products to a large number of distributors in a number of countries worldwide. Revenue in the year ended 31 December 2015 is expected to be €19 million.

 

Bunzl has also acquired Emilio Saray Y Compania Limitada, trading as DPS, a distributor of catering disposables and a variety of cleaning, safety and packaging products based in Santiago with a number of other locations throughout Chile. Customers include wholesalers and distributors as well as restaurants, supermarkets and other end users. Revenue in 2015 is expected to be CLP25.4bn (c.£24 million).

 

Finally in Spain the Company has purchased Faru S.L. Based in Zaragoza, the business is engaged in the sale of personal protection equipment, including fall arrest and head protection products and safety shoes, to distributors throughout Spain. Revenue in 2015 is expected to be €5 million.

 

The Company has now acquired 21 businesses so far this year with a total committed acquisition spend of £320 million which is a record level of spend for Bunzl in any one year. Bunzl's strong cash flow and balance sheet and the continuing promising pipeline of further acquisition opportunities should enable the Group to consolidate further the markets in which it competes and continue to increase shareholder value.

 

Commenting on the acquisitions, Michael Roney, Chief Executive of Bunzl, said:

 

"The acquisition of Comatec is a significant addition to our strong business in France and expands our operations into the foodservice sector where we are already a leader in many countries. The purchase of DPS in Chile extends our business there into the foodservice and cleaning and hygiene sectors in a country where we have previously built a strong anchor position in the safety sector. Faru will complement our existing safety business in Spain by further enhancing our product offering. We are pleased to welcome the employees of all three businesses to the Group."

 

Enquiries:

Bunzl plc

Michael Roney, Chief Executive

Brian May, Finance Director

Tel: +44 (0)20 7725 5000

Tulchan

David Allchurch

Stephen Malthouse

Tel: +44 (0)20 7353 4200

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBSBDDGBBBGUU
Date   Source Headline
29th Jun 20233:26 pmRNSDirector/PDMR Shareholding
21st Jun 20234:54 pmRNSHolding(s) in Company
15th Jun 20237:00 amRNSTrading Statement
8th Jun 20238:00 amRNSAdditional Listing
5th Jun 202311:00 amRNSDirector/PDMR Shareholding
1st Jun 202311:16 amRNSTotal Voting Rights
30th May 20237:00 amRNSAcquisition
24th May 202312:16 pmRNSHolding(s) in Company
18th May 20238:00 amRNSAdditional Listing
3rd May 20234:15 pmRNSDirector/PDMR Shareholding
2nd May 20234:51 pmRNSDirector/PDMR Shareholding
2nd May 202310:37 amRNSDirector/PDMR Shareholding
2nd May 202310:30 amRNSTotal Voting Rights
2nd May 202310:27 amRNSBlock listing Interim Review
27th Apr 20238:00 amRNSAdditional Listing
26th Apr 20234:34 pmRNSResult of AGM
26th Apr 20237:00 amRNSTrading Statement
20th Apr 20238:00 amRNSAdditional Listing
19th Apr 20235:20 pmRNSHolding(s) in Company
13th Apr 20235:06 pmRNSDirector/PDMR Shareholding
12th Apr 20234:43 pmRNSDirector/PDMR Shareholding
11th Apr 20232:10 pmRNSDirector/PDMR Shareholding
11th Apr 20232:10 pmRNSDirector/PDMR Shareholding
11th Apr 202310:25 amRNSDirector/PDMR Shareholding
11th Apr 202310:17 amRNSDirector/PDMR Shareholding
5th Apr 20234:59 pmRNSDirector/PDMR Shareholding
3rd Apr 202312:30 pmRNSTotal Voting Rights
3rd Apr 202310:30 amRNSDirector/PDMR Shareholding
3rd Apr 20239:35 amRNSDirector/PDMR Shareholding
30th Mar 20238:00 amRNSAdditional Listing
28th Mar 202310:58 amRNSDirector/PDMR Shareholding
28th Mar 20239:21 amRNSDirector/PDMR Shareholding
23rd Mar 20238:00 amRNSAdditional Listing
16th Mar 202312:07 pmRNSAnnual Financial Report
16th Mar 20238:00 amRNSAdditional Listing
3rd Mar 20234:56 pmRNSDirector/PDMR Shareholding
2nd Mar 20233:20 pmRNSDirector/PDMR Shareholding
2nd Mar 202312:13 pmRNSDirector/PDMR Shareholding
2nd Mar 202312:09 pmRNSDirector/PDMR Shareholding
1st Mar 20234:31 pmRNSTotal Voting Rights
1st Mar 20234:02 pmRNSDirector/PDMR Shareholding
27th Feb 20232:00 pmRNSDividend Declaration
27th Feb 20237:00 amRNSFinal Results
27th Feb 20237:00 amRNSAcquisition
7th Feb 20237:00 amRNSDirectorate Change
6th Feb 20232:22 pmRNSDirector/PDMR Shareholding
2nd Feb 20237:00 amRNSCUSTOMER CONTRACT
1st Feb 202310:19 amRNSTotal Voting Rights
10th Jan 20233:44 pmRNSDirector/PDMR Shareholding
6th Jan 20234:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.